Stockreport

Foundation Medicine Announces Expanded Participation in National Cancer Institute's ComboMATCH Platform Trials Through Inclusion of Its High-Quality Blood-Based Biomarker Test, FoundationO...

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF BOSTON, March 10, 2026 BUSINESS WIRE Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced its expanded participation with th [Read more]